SRTA 8-K 2026-11-03

Strata Critical Medical, Inc. (SRTA) 8-K dated 2026-11-03 — accession 0001628280-26-069117.

Strata Critical Medical, Inc. (SRTA) common stock.

Strata Critical Medical, Inc. filed a 8-K on 2026-11-03. Accession 0001628280-26-069117.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SRTA revenue for 2025-12-31 was $197.1M. Net income was $41.3M. Revenue was down 20.7% from 2024-12-31 to 2025-12-31. SRTA currently screens at market cap $396.6M and trailing P/E 9.1.

Not investment advice. The SRTA SEC hub lists recent forms. The stock page is the research view.